Fungal polyketides are a diverse class of natural products that possess many pharmacological properties, including anticancer properties. These properties are evident in the resorcylic acid lactones, a family of polyketides, including zearalenone and radicicol, which shows potent inhibition of tumour cell growth. The key step in the biosynthesis of these lactones is macrocyclization of a linear carboxylic acid into the macrolactone. This reaction is catalyzed by a polyketide synthase (PKS) thioesterase enzyme. Bacterial PKS thioesterases (TEs) have been extensively studied and their substrate specificity has been characterized in vitro. They are highly substrate selective for the macrocyclization reaction. Since Fungal PKS TEs show little sequence homology to bacterial TEs, we have begun investigating their substrate specificity. In particular we are examining the ability of fungal TEs to macrocyclize compounds with varying ring sizes, stereogenic configuration, and nucleophiles. Herein we present the synthesis of a number of diverse TE substrates and the in vitro macrocyclization results for the TEs from zearalenone and radicicol biosynthetic pathway with these substrates.

Universiẗat, Diss., 2001--Münster (Westfalen).

ÉTUDES VERS LA SYNTHESE TOTALE DE LA (+)-TAUTOMYCETINE: La (+)-tautomycétine (2 ,TTN), polycétide naturel isolé en 1989 à partir de souches de Streptomyces griseochromogenes possède, en plus de sa structure chimique unique, des activités biologiques prometteuses. Plus récemment, comme étant un inhibiteur spécifique des sérine/thréonine phosphatases de type 1 (PP1) et 2A (PP2A). Nous nous sommes intéressés au développement d'une voie de synthèse pour accéder à la (+)-tautomycétine. Nous avons réussi à synthétiser les deux fragments principaux de la tautomycétine, le fragment B2 correspondant à la partie C1-C12 et compos 260, qui constitue la partie C7'-C13. Ces deux fragments contiennent tous les carbones de la TTN. / STUDIES TOWARD THE TOTAL SYNTHESIS OF (+)-TAUTOMYCETIN: (+)-Tautomycetin is a polyketide natural product isolated in 1989 from Streptomyces griseochromogenes with antifungal activity. Currently, TTN is best known for its activity in serine/threonine phosphatase proteins. We developed a convergent synthetic route to this natural product. Two key fragments of (+)-tautomycetin were synthesized, the B2 fragment containing the C1-C12 chain and the compound 260, corresponding to the C7'-C13 fragment of (+)-tautomycetin. The synthesis of fragment B2 employed a stereoselective chiral epoxide opening reaction as a key step, which consist of a novel strategy to prepare the desoxypropionate moiety of TTN. The synthesis of 260 employed a novel method for bis-esterification of anhydrides developed in the Dias-Campagne groups

Les cyanobactéries sont des procaryotes photosynthétiques ubiquitaires qui produisent un grand nombre de métabolites secondaires, dont des toxines. Parmi ces cyanotoxines, l'anatoxine-a est une neurotoxine puissante qui provoque une mort rapide après ingestion. La mort est causée par asphyxie car ces alcaloïdes sont de puissants agonistes du récepteur nicotinique de l'acétylcholine.L'équipe, au sein de laquelle j'ai effectué ma thèse, étudie la biosynthèse de l'anatoxine-a et de ses dérivés, chez les cyanobactéries. Des travaux précédents de l'équipe ont permis d'identifier le cluster de gènes responsable de la biosynthèse de l'anatoxine-a et de l'homoanatoxine-a, dans le génome de la cyanobactérie Oscillatoria sp. PCC 6506, une souche productrice d'homoanatoxine-a. Une voie de biosynthèse, à partir de la proline a été proposée par l'équipe.J'ai travaillé sur l'étude des dernières étapes de cette voie de biosynthèse, qui met probablement en jeu une polyketide synthase (PKS) AnaG et une thioestérase AnaA. Lors de ces étapes le précurseur de l'homoanatoxine-a est condensé à une unité acétate, puis subirait une méthylation, une hydrolyse et une décarboxylation, pour donner l'homoanatoxine-a. Néanmoins, la PKS AnaG ne possède ni domaine thioestérase ni domaine décarboxylase, et les dernières étapes de la biosynthèse sont donc mal définies. Nous avons décidé d'exprimer différents domaines d'AnaG chez Escherichia coli pour obtenir plus d'informations sur ces étapes. Nous avons également tenté de préparer un analogue du substrat putatif d'AnaG par synthèse chimique.Par ailleurs, nous avons étudié la biosynthèse de la dihydroanatoxine-a chez Cylindrospermum stagnale PCC 7417. / Cyanobacteria are photosynthetic ubiquiterious prokaryotes which produce a high range of secondary metabolites including toxins. Among these cyanotoxins anatoxin-a is a potent neurotoxin which causes the rapid death on ingestion. The death is caused by respiratory failure because these alkaloid are potent agonists of the nicotinic alcetylcholine receptor. The team in which I did my PhD thesis studies the biosynthesis of anatoxin-a and of its derivatives in cyanobacteria. Preceding works by our team have permitted the identification of the cluster of genes that is responsible for the biosynthesis of anatoxin-a and homoanatoxin-a in the cyanobacterium Oscillatoria sp. PCC 6506. A biosynthetic pathway from proline was also proposed by the team. I have worked on the final stages of this biosynthesis pathway which probably involves a polyketide synthase (PKS), AnaG, and a thioesterase, AnaA. During these stages, the homoanatoxin-a precursor is likely condensed to one acetate unit, and then it is subjected to a methylation, a hydrolysis and a decarboxylation , to yield homoanatoxin-a. The PKS AnaG possesses neither a thioesterase domain nor a decarboxylase domain, and the last steps of the biosynthesis are therefore not well defined. We have chosen to express different domains of AnaG in Escherichia coli to obtain more information on these steps. We have also attempted by chemical synthesis to prepare an analog of the substrate of AnaG. With these tools in hand and with the use of mass spectrometry we hope to be able to confirm the biosynthetic pathway we have put forth. We have also studied the biosynthesis of dihydroanatoxin-a in Cylindrospermum stagnale PCC 7417.

Fungal polyketides are a diverse class of natural products that possess many pharmacological properties, including anticancer properties. These properties are evident in the resorcylic acid lactones, a family of polyketides, including zearalenone and radicicol, which shows potent inhibition of tumour cell growth. The key step in the biosynthesis of these lactones is macrocyclization of a linear carboxylic acid into the macrolactone. This reaction is catalyzed by a polyketide synthase (PKS) thioesterase enzyme. Bacterial PKS thioesterases (TEs) have been extensively studied and their substrate specificity has been characterized in vitro. They are highly substrate selective for the macrocyclization reaction. Since Fungal PKS TEs show little sequence homology to bacterial TEs, we have begun investigating their substrate specificity. In particular we are examining the ability of fungal TEs to macrocyclize compounds with varying ring sizes, stereogenic configuration, and nucleophiles. Herein we present the synthesis of a number of diverse TE substrates and the in vitro macrocyclization results for the TEs from zearalenone and radicicol biosynthetic pathway with these substrates.

The Sigma-54 Promoter Database contains computationally predicted sigma-54 promoters from over 60 prokaryotic species. Organisms from all major phyla were analysed and results were made available online at http://www.sigma54.ca. This database is particularly unique due to its inclusion of intragenic regions, grouping of data by COG and COG category, and the ability to summarize results either by phylum or database-wide. ClusterMine360 (http://www.clustermine360.ca/) is a database of microbial polyketide and nonribosomal peptide gene clusters. It takes advantage of crowd-sourcing by allowing members of the community to make contributions while automation is used to help achieve high data consistency and quality. The database currently has over 200 gene clusters from over 185 compound families. It also features a unique sequence repository containing over 10,000 PKS/NRPS domains. The sequences are filterable and downloadable as individual or multiple sequence FASTA files. This database will be a useful resource for members of the PKS/NRPS research community enabling them to keep up with the growing number of sequenced gene clusters and rapidly mine these clusters for functional information.

Orientadores: Luiz Carlos Dias, Jean-Marc Campagne / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Química / Made available in DSpace on 2018-08-26T12:59:10Z (GMT). No. of bitstreams: 1 Sant'ana_DaniloPereirade_D.pdf: 12186591 bytes, checksum: 82263f5c920d42c10acf04cf823af93f (MD5) Previous issue date: 2014 / Resumo: SÍNTESE DO FRAGMENTO C1-C9 DA (-)-DICTIOSTATINA: A (-)-dictiostatina é uma macrolactona de origem marinha que apresenta uma potente atividade antitumoral, inibindo a proliferação de células cancerígenas em concentrações na ordem de nanomolar. Propusemos desenvolver uma nova rota sintética para o fragmento C1-C9 deste produto natural. Conseguimos sintetizar o fragmento C1-C9 da (-)-dictiostatina em 15 etapas a partir do 1,3-propanodiol com 3,57% de rendimento global. Nossa rota sintética utilizou como etapas chaves a epoxidação assimétrica de Sharpless e a abertura de epóxido nas condições de Myashita para formar os centros estereogênicos. Este fragmento compreende os carbonos C1-C9 da (-)-dictiostatina, no qual está contido o dieno 2Z,4E e dois centros estereogênicos (C6R, C7S do produto natural). ESTUDOS VISANDO A SÍNTESE TOTAL DA (+)-TAUTOMICETINA: A (+)-tautomicetina é um policetídeo natural isolado em 1989 a partir de Streptomyces griseochromogenes como um antifúngico. Atualmente, TTN é mais conhecida pela sua atividade em proteínas serina/treonina fosfatases. Propusemos desenvolver uma rota sintética convergente para este produto natural. Conseguimos sintetizar dois fragmentos da tautomicetina, sendo o fragmento B2 correspondendo a parte C1-C12 e o composto 260 que consiste na parte C7¿-C13 da (+)-tautomiceina. A síntese do fragmento B2 teve como etapa chave a abertura estereosseletiva de epóxido quiral, o que consiste uma estratégia inédita para construir a parte desoxipropionato da TTN. A síntese do composto 260 teve como etapa chave, uma metodologia inédita de bis-esterificação de anidridos desenvolvida em nosso grupo de pesquisa / Abstract: SYNTHESIS OF THE C1-C9 FRAGMENT OF (-)-DICTYOSTATIN: (-)-Dictyostatin is a marine macrolactone with potent antitumor activity. Herein, we report the development of a new synthetic route for the C1-C9 fragment of this natural product. The C1-C9 fragment of (-)-dictyostatin was synthesized in 15 steps and 3.57% overall yield from 1,3-propanediol. Our synthetic route employed Sharpless asymmetric epoxidation and epoxide opening under Myashita's conditions as key steps to form the stereogenic centers. The C1-C9 fragment contains the 2Z,4E diene and two stereogenic centers (C6R, C7S) contained in the natural product. STUDIES TOWARD THE TOTAL SYNTHESIS OF (+)-TAUTOMYCETIN: (+)-Tautomycetin is a polyketide natural product isolated in 1989 from Streptomyces griseochromogenes with antifungal activity. Currently, TTN is best known for its activity in serine/threonine phosphatase proteins. We developed a convergent synthetic route to this natural product. Two key fragments of (+)-tautomycetin were synthesized, the B2 fragment containing the C1-C12 chain and the compound 260, corresponding to the C7'-C13 fragment of (+)-tautomycetin. The synthesis of fragment B2 employed a stereoselective chiral epoxide opening reaction as a key step, which consist of a novel strategy to prepare the desoxypropionate moiety of TTN. The synthesis of 260 employed a novel method for bis-esterification of anhydrides developed in the Dias-Campagne groups / Doutorado / Quimica Organica / Doutor em Ciências

This research is focused on investigation and engineering of natural product biosynthetic pathways for efficient production of pharmaceutically important molecules or generation of new bioactive molecules for drug development. Natural products are an important source of therapeutics, such as chromomycin (anti-cancer), emodin (anti-inflammatory and anti-tumor) and sprolaxine (anti-Helicobacter pylori). Metabolic engineering of natural product biosynthetic pathways shows its promise for creating and producing valuable compounds with chemical diversity for drug discovery. One goal of this research is to create highly efficient strains to biosynthesize valuable natural products. The engineered Streptomyces roseiscleroticus strain constructed in this work showed higher titers of chromomycins than previously reported, which was achieved by characterizing and engineering the chromomycin biosynthetic gene cluster. I activated the polyketide biosynthetic pathway by engineering two regulatory genes, and optimized the culture conditions to increase the titer of chromomycins. The production of emodin nowadays mostly relies on conventional plant cultivation and organic solvent extraction, which is time-consuming and cost-ineffective. This work built a biosynthetic platform using industrial strains Saccharomyces cerevisiae and Pichia pastoris with eight genes from fungi and yeast, which affords a more efficient biosynthetic process of emodin. On the other hand, we used Escherichia coli as a platform for heterologous expression of PKSs and engineering of particular biosynthetic pathways to generate chemical diversity in natural products. The type III polyketide synthase (PKS) involved in the biosynthesis of spirolaxine was identified in this research, which is important for complete elucidation of the biosynthetic pathway of this anti-Helicobacter pylori natural product. Heterologous expression of this PKS in E. coli generated five new pharmaceutically valuable alkylresorcinols. Addition of glucose or pyruvate into the fermentation broths of E. coli expressing another type III PKS StTS resulted in a significant change in the product profiles. Five new products are produced and structurally characterized. Therefore, this work provides a new approach to generating new bioactive molecules in E. coli, the most widely used heterologous expression host.

Strain MS14, exhibiting antifungal activity, was classified to belong to Burkholderia contaminans. Occidiofungin produced by strain MS14 is an octapeptide dedicated to a broad range of antifungal activities of the bacterium. The 58.2-kb genomic fragment containing 18 open reading frames (ORFs), named occidiofungin (occ) gene cluster, is required for occidiofungin production. Putative proteins encoded by five nonribosomal peptide synthetase genes (occA – occE) of the gene cluster were predicted to contain the catalytic modules responsible for the biosynthesis of occidiofungin. Transcription of all the ORFs identified in the region except ORF1 and ORF16 was regulated by both ambR1 and ambR2, the LuxR-type regulatory genes located at the left border of the cluster. The functional ambR1 gene was essential for transcription of ambR2, and constitutive expression of ambR2 did not restore the phenotype of the mutant MS14GG44(ambR1::nptII). Sequence analysis revealed that the occ gene cluster shared high similarity (99% nucleotide coverage and 91% identity) to an uncharacterized DNA region of B. ambifaria strain AMMD. The gene cluster was not found in other Burkholderia strains available in GenBank (nucleotide coverage < 24%). Analysis of G+C composition and prediction using “IslandPick” indicate that the occ gene cluster has possibly been horizontally transferred between bacteria. In addition, the absence of the gene cluster in clinical strains of Burkholderia indicates that occidiofungin is not required for potential human pathogenesis. The findings have provided insights into the development of antifungal medicines and agricultural fungicides based on occidiofungin.

In sea urchin development, cell fate specification appears by the 60-cell stage embryo when several embryonic territories are recognized: the small micromeres, the large micromeres which will generate primary mesenchyme cells, the vegetal2 layer that will give rise to pigment cells, immunocytes, and muscle cells, the vegetal1 layer, as well as the oral and aboral ectoderm. A Delta-Notch signaling event is required for the differential specification of mesodermal cells that will give rise to secondary mesenchyme cells (SMCs). SMCs produce four cell types: pigment cells, blastocoelar cells, circumesophageal muscle cells, and coelomic pouch cells. Pigment cells are the first to be specified. During primary invagination at the gastrula stage, eight pigment cell progenitors delaminate from the archenteron into the blastocoel. By the pluteus stage, approximately 30 pigment cells are embedded in the ectoderm. Pigment cells produce echinochrome, a napthoquinone pigment. Previously, several genes in the sea urchin embryo were isolated that are expressed specifically in pigment cell precursors during the blastula stage. The goal of this research was to characterize a subset of these genes, which are highly similar to: the polyketide synthase gene (Pks), a sulfotransferase gene (Sult), three different members of the flavin-containing monooxygenase gene family (Fmo), and the transcription factor glial cells missing (Gcm). Polyketide synthases (PKSs) are a large family of multifunctional proteins mainly found in bacteria, fungi, and plants. They are responsible for the biosynthesis of a variety of polyketide compounds including antibiotics and mycotoxins. In the sea urchin, SpPks is required for echinochrome biosynthesis. Flavin-containing monooxygenases (FMOs) are NADPH-dependent flavoproteins mainly found in bacteria, plants, and higher metazoan. They are responsible for catalyzing the oxidation of several compounds including the detoxification of xenobiotics and activation of numerous metabolites. It is known that SpFmo1 is required for echinochrome biosynthesis. Sulfotransferases are found from bacteria through higher eukaryotes. These enzymes catalyze the sulfate conjugation of several substrates resulting in either compound detoxification or bioactivation.